← Back to Search

Other

Potato starch supplement for Type 2 Diabetes

N/A
Waitlist Available
Led By Scott Hummel, MD, MS
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, approximately 4 weeks
Awards & highlights

Study Summary

This trial is looking at how adding potato starch to a person's diet can change the types of bacteria in their gut and help these bacteria produce short chain fatty acids, which could be good for the person

Who is the study for?
This trial is for individuals with heart failure that still have a normal amount of blood pumped from their heart (HFpEF) and also have type 2 diabetes. Participants should be interested in adding dietary fiber to their diet.Check my eligibility
What is being tested?
The study is testing the effects of potato starch as a dietary supplement on gut bacteria and its byproducts in people with HFpEF and type 2 diabetes. The goal is to see if this can produce more beneficial fatty acids for health.See study design
What are the potential side effects?
While not explicitly stated, potential side effects may include digestive changes such as bloating, gas, or altered bowel movements due to increased fiber intake.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, approximately 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, approximately 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in Short Chain Fatty Acid (SCFA) butyrate levels - plasma
Changes in Short Chain Fatty Acid (SCFA) butyrate levels - stool
Changes in acetate levels- plasma
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Potato starch supplementExperimental Treatment1 Intervention
Participants will take the supplement for approximately 4 weeks.

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,796 Previous Clinical Trials
6,377,923 Total Patients Enrolled
Scott Hummel, MD, MSPrincipal InvestigatorUniversity of Michigan

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment of participants currently ongoing for this research study?

"According to clinicaltrials.gov, this specific research project is currently not seeking volunteers. The trial's initial posting was on April 1st, 2024, with the most recent update made on March 22nd of the same year. Despite its current inactivity, it's worth noting that there are a substantial 802 other trials actively seeking participants at present."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)
Scott L. Hummel 2024. "Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06337812.
~20 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top